［1］Danny Chan.Precision cancer therapeutics for glioma［J］.Glioma，2018，1(5)：155-158.
[2]Feiyifan Wang,Christopher Pirozzi，Xuejun Li.Glioma research in the era of medical big data［J］.Cancer Translational Medicine，2018，4(4)：95-101.
[3]Haase S，Garcia-Fabiani MB，Carney S，et al.Mutant ATRX：Uncovering a new therapeutic target for glioma［J］.Expert Opinion on Therapeutic Targets，2018，22(7)：599-613.
[4]Boussiotis VA，Charest A.Immunotherapies for malignant glioma［J］.Oncogene，2018，37(9)：1121-1141.
[5]Hiva Danesh，Mohammad Hashemi，Fatemeh Bizhani，et al.Association study of miR-100，miR-124-1，miR-218-2，miR-301b，miR-605，and miR-4293.Polymorphisms and the risk of breast cancer in a sample of Iranian population［J］.Gene：An International Journal Focusing on Gene Cloning and Gene Structure and Function，2018(647)：73-78.
[6]Lian SZ，Liu XD，Wang HQ，et al.Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1［J］.Current Pharmaceutical Design，2013，19(35)：6382-6389.
[7]LI CF，JING W，XIANG DS，et al.Expression of microRNA-613 in human glioma and its effect on proliferation and metastasis［J］.Journal of Anatomy，2018，49(5)：579-583.［李传芬，荆文，向冬生，等.MicroRNA-613在人胶质瘤中的表达及其对增殖与转移的影响［J］.解剖学报，2018，49(5)：579-583.］
[8]DUAN JW，TANG XP，ZHANG T，et al.Upregulation of microRNA-34a inhibits proliferation and invasion of glioma cells［J］.Anhui Medicine，2018，39(1)：6-9.［段军伟，唐晓平，张涛，等.上调microRNA-34a抑制胶质瘤细胞的增殖及侵袭［J］.安徽医学，2018，39(1)：6-9.］
[9]JIN XY，FU C，YU WD，et al.Present situation and progress of biological research on glioma［J］.Chinese Experimental Diagnostics，2019，23(1)：147-151.［金星一，付超，于伟东，等.神经胶质瘤的生物学研究现状及进展［J］.中国实验诊断学，2019，23(1)：147-151.］
[10]Li B，Chang H，Lin YC，et al.Cutaneous metastases of the glioma［J］.The Journal of Craniofacial Surgery，2018，29(1)：E94-E96.
[11]Sara Hanaei，Khashayar Afshari，Armin Hirbod-Mobarakeh，et al.Therapeutic efficacy of specific immunotherapy for glioma：A systematic review and meta-analysis［J］.Reviews in the Neurosciences，2018，29(4)：443-461.
[12]Muhammad Samad，Karim Nathani，Usama Choudry，et al.Evidence-based advances in glioma management［J］.IJS Short Reports，2018，3(1)：36-42.
[13]Cheng WT，Fu Y.Research progress of miR-211［J］.Modern Oncology，2016，24(3)：473-475.
[14]Calin GA，Sevignani C，Hyslop T，et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers［J］.Proceedings of the National Academy of Sciences of the United States of America，2004，101(9)：2999-3004.
[15]Chu GM，Zhang JB，Chen XB.Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer［J］.Journal of Drug Targeting，2016，24(7)：613-617.
[16]Yang LJ，Xie H，Wang CL，et al.Study on the differential expression profile of microRNA in glioma tissues［J］.Chinese and Foreign Medical Research，2010，8(6)：1-3.
[17]Robb T，Reid G，Blenkiron C.Exploiting microRNAs as cancer therapeutics［J］.Target Oncol，2017，12(2)：163-178.
[18]Zhang H，Zhang YL，Liu Z.MicroRNA-147 suppresses proliferation，invasion and migration through the AKT/mTOR signaling pathway in breast cancer［J］.Oncology Letters，2016，11(1 Pt.A)：405-410.
[19]Uhlmann S，Mannsperger H，Zhang JD，et al.Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer［J］.Molecular Systems Biology，2012，14(8)：570-570.
[20]Yang JR，Wang WY.Mechanism of miR-147 targeting MDM2 regulating proliferation and apoptosis of ovarian cancer cell line Skov3［J］.J Clin Oncol，2017，22(2)：118-123.